Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05218811 · ClinicalTrials.gov registry record · NA
Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach
A NA study of Kidney Neoplasms, sponsored by Urological Research Network.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05218811: Recruiting NA study of Kidney Neoplasms, sponsored by Urological Research Network.
NCT05218811 is a NA study of Kidney Neoplasms that is actively recruiting participants, run by Urological Research Network. The registered enrollment target is 150 participants, below the 371-participant average among 9 other Kidney Neoplasms trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05218811, a NA study of Kidney Neoplasms, is actively recruiting participants, sponsored by Urological Research Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with renal masses eligible to partial nephrectomy often require arterial ischemia to control or prevent blood loss during this surgical procedure. This study aims to determine the safety and efficacy of renal cryoablation at the tumor bed, as a substitute measure or technique vs total or selective arterial renal ischemia.
Primary Outcome
Recurrence at Site of Excision or within 1 cm of margin or Development of Metastasis
Conditions Studied
Interventions
- DEVICE Cryoablation Assisted Partial Nephrectomy
Study Locations (1)
Florida
- Urological Research Network - Miami Lakes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-05-15 |
| Est. Completion | 2041-05-15 |
| Phase | NA |
What NCT05218811 shows while recruiting
NCT05218811 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 371-participant average among 9 other Kidney Neoplasms trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Kidney Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Cryoablation Assisted Partial Nephrectomy is the first listed.
NCT05218811 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05218811 about?
NCT05218811 is a clinical study titled "Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach". Patients with renal masses eligible to partial nephrectomy often require arterial ischemia to control or prevent blood loss during this surgical procedure. This study aims to determine the safety and efficacy of renal cryoablation at the tumor bed, as a substitute measure or technique vs total or se...
What is the current status of trial NCT05218811?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2020-05-15. Estimated completion is 2041-05-15.
What conditions does trial NCT05218811 study?
This clinical trial studies the following conditions: Kidney Neoplasms.
What interventions are being tested in trial NCT05218811?
The interventions under investigation include: Cryoablation Assisted Partial Nephrectomy (DEVICE).
Who is sponsoring clinical trial NCT05218811?
This trial is sponsored by Urological Research Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05218811 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05218811's enrollment target sits among peer trials
150 3rd of 9 higher than 7 of 9 other Kidney Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RECRUITING
-
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
RECRUITING · Phase 2
-
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
RECRUITING
-
Savolitinib vs. Sunitinib in MET-driven PRCC.
ACTIVE NOT RECRUITING · Phase 3
-
Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors
COMPLETED · Phase 1
-
A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI